Lasers News

Galderma has announced in a press release that launch of Mom Genes, a campaign to educate women on the genetics of facial aging, and to open dialogue on the subject between mothers and daughters.

Findings that fractional microneedling plus topical anesthesia decreased pain sensation better than topical anesthesia alone when used prior to microneedling procedures for treating postacne scarring was among recent developments in cosmetic dermatology reported on Healio.com.

The American Society for Dermatologic Surgery recently announced it is holding its second annual resident cosmetic symposium that will focus on patient safety and achieving optimal cosmetic results, according to a press release.

A 532-nm potassium titanyl phosphate laser was as safe and effective as a 595-nm pulsed dye laser in treating erythematous surgical scars, according to recently published study results.

Research showing that combination therapy with topical calcineurin inhibitors and excimer laser/light was more effective than excimer laser/light monotherapy in treating vitiligo was among the laser developments recently reported on Healio.com.

Patients with stretch marks displayed clinical and histopathological improvements after treatment with 1540-nm and 1410-nm nonablative fractionated lasers, according to recently published study results.

Combination therapy with topical calcineurin inhibitors and excimer laser/light was more effective than excimer laser/light monotherapy in treating vitiligo, according to the recent study results.

WAIKOLOA, Hawaii — Intense pulsed light therapy may be used as a non-ablative laser therapy for dry eye, according to a speaker here.

Study results finding that combination therapy including a 308-nm excimer laser, topical tacrolimus and short-term systemic corticosteroids was effective for treating patients with segmental vitiligo was 2015’s most-read article in Healio.com/Dermatology related to laser treatment.

Recent actions reported on Healio.com/Aesthetics include the FDA granting additional indications for the use of Syneron Candela’s CO2 device.